ABA Practice Valuation: What Buyers Actually Pay, and Why

The email arrives unsolicited. Someone from a platform you have vaguely heard of would like to have a confidential conversation about your clinic, and they use the word "partnership" at least twice.

Most owners delete it. Some reply out of curiosity, get quoted a multiple that sounds enormous, and spend the next six months discovering that the number attached to their business is considerably smaller than the number they heard. The gap between those two figures is not deception. It is the difference between what platform-quality practices trade for and what a specific practice with real operational gaps is worth to a buyer who has looked at the books.

Understanding that gap is worth doing even if you never intend to sell, because almost everything that raises a valuation is also what makes a clinic easier to run.

What ABA practices are selling for

The honest answer is that published ranges disagree with each other, and the disagreement is informative.

Advisory firms tracking the sector put quality ABA agencies somewhere around 5x to 8x EBITDA in 2026, with multi-state platforms at the upper end. Others report small pediatric therapy practices in occupational, physical, and speech therapy trading closer to 3x to 6x, with larger ABA practices and platform-level companies reaching 6x into the low teens. Research looking specifically at small listed businesses, where owner involvement is heavy and unclear, finds a median closer to 3.4x cash flow.

Those ranges are not contradicting each other so much as describing different businesses. A single-site clinic where the owner is also the clinical director sits at the bottom. A regional operator with ten locations, a management team, and diversified payers sits near the top. The spread between them is roughly four times the same earnings.

For context on the ceiling, Webster Equity Partners sold InBloom Autism Services near the end of 2025 to Elysium Management for a reported $75 million at approximately 15x EBITDA. That is a platform transaction, not a comparable for an independent clinic, and it is useful mainly as a reminder that the headline multiples circulating in the market belong to a different category of business.

Worth noting where these figures come from. Nearly every transaction in this sector is private, so published multiples come from M&A advisory firms with a commercial interest in encouraging deal activity. Treat them as directional.

Why 2026 specifically matters

There is a structural reason the outreach emails have picked up.

Private equity has been consolidating ABA since around 2015, and the standard hold period is four to five years. As of year-end 2025, one firm tracking the sector counted 13 pediatric therapy platforms held longer than seven years and another 22 held five to seven, meaning more than 35 platforms sitting in or past their expected exit window. Sponsors need to return capital to their investors, which points toward a wave of secondary buyouts and strategic sales.

Platforms preparing to exit need growth to show, and bolt-on acquisitions are the fastest way to produce it. That is why independent clinics with five to twenty locations, and increasingly smaller ones, are getting contacted.

Valuations have also come down from the 2020 and 2021 peak, when mid-market agencies routinely traded at 8x to 10x and platform deals went higher. The market today is more selective and still active for operators who can demonstrate the things buyers check.

What actually determines your number

Buyers start with normalized EBITDA, meaning your earnings adjusted for things a new owner would not inherit, most commonly an owner's above-market compensation, personal expenses running through the business, and one-time costs. Then they adjust the multiple based on operational factors, and this is where most of the value is won or lost.

Owner dependence is the single largest discount for small practices. If you are the clinical director, the relationship owner, and the person who resolves every escalation, a buyer is purchasing a job rather than a business. Practices with a management team that runs without the owner trade materially higher.

Payer mix and concentration. Heavy dependence on one payer, or on a state Medicaid program that just cut rates, introduces risk that gets priced in directly. Diversification across commercial and government payers reads as durability.

Documentation and compliance. Buyers examine authorization currency, session note quality, supervision records, and credentialing, because improper payments identified after a sale become the buyer's problem. The federal audit activity across ABA in recent years has made this a more serious part of diligence than it was five years ago, and a practice with documentation gaps either takes a lower price or absorbs a larger escrow.

Clean, segmented financials. If your books cannot show margin by payer or separate direct labor from administrative labor, diligence takes longer, costs more, and produces uncertainty that buyers resolve in their own favor. Practices with three years of reviewed statements and a chart of accounts that answers questions get better terms.

Staff stability. Turnover in this field runs high, and a buyer paying for capacity wants evidence the capacity stays. Retention data is diligence material.

Collections performance. Net collection rate, days in AR, and denial trends tell a buyer whether the revenue is real and whether there is upside available from fixing something.

The part owners underestimate

The headline multiple is not the deal. What you actually receive depends on net debt, working capital adjustments, escrow holdbacks, equity rollover, and earnouts, and these routinely move the effective price more than a half-turn of multiple would.

An earnout tied to post-close performance can represent a meaningful share of the total, payable only if targets are met under someone else's operating decisions. A rollover means part of your proceeds stay invested in the combined entity and depend on its eventual exit. Neither is inherently bad and both belong in the conversation early, because a higher headline number with heavier structure can be worth less than a lower one paid in cash.

Why this matters if you are not selling

Every item on the list above describes a better-run clinic.

A practice that operates without the owner in every decision is a practice where the owner can take a vacation. Diversified payers survive a rate cut that would damage a concentrated one. Documentation strong enough for diligence is documentation strong enough for an audit. Books that answer questions for a buyer answer them for you first, and the metrics a buyer examines are the same ones worth watching every month regardless.

The sequence matters. Exit readiness is not a project you start when you decide to sell, because the changes take two to three years to show up in the numbers a buyer examines. Owners who begin the work with no intention of selling end up with both a more valuable business and a better one to own.

Back to the email

The unsolicited outreach is worth reading, even if the answer is no. It tells you the market is active in your segment, and it is a reasonable prompt to find out what your practice would actually be worth rather than what a stranger's opening number suggests.

The more useful question is not whether to sell. It is whether your clinic would survive diligence today, because the answer to that one determines your options whenever you do decide.

Frequently asked questions about ABA practice valuation

What EBITDA multiple do ABA practices sell for?

Published ranges vary by source and by practice size. Advisory firms report quality ABA agencies around 5x to 8x in 2026, with larger platforms reaching into the low teens and very small owner-dependent practices trading considerably lower.

What is normalized EBITDA?

Earnings adjusted to reflect what a new owner would actually inherit, removing above-market owner compensation, personal expenses, and one-time items.

Why do small ABA practices sell for lower multiples?

Owner dependence, payer concentration, limited management depth, and less formal financial and compliance infrastructure all increase the buyer's risk and reduce what they will pay.

How long does it take to prepare an ABA practice for sale?

Typically two to three years, since buyers examine multi-year trends in financials, retention, and compliance rather than a single strong year.

Does a high headline multiple mean a good deal?

Not on its own. Escrow, earnouts, rollover equity, and working capital adjustments can move the effective proceeds substantially.

If you want to understand what your practice is worth and which gaps are costing you the most, that is exactly the kind of work our financial assessment is built to do.